GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » Other Operating Expense

SciBase Holding AB (OSTO:SCIB) Other Operating Expense : kr0.21 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB Other Operating Expense?

SciBase Holding AB's Other Operating Expense for the three months ended in Dec. 2024 was kr-0.16 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.21 Mil.

SciBase Holding AB's quarterly Other Operating Expense increased from Jun. 2024 (kr0.13 Mil) to Sep. 2024 (kr0.25 Mil) but then declined from Sep. 2024 (kr0.25 Mil) to Dec. 2024 (kr-0.16 Mil).

SciBase Holding AB's annual Other Operating Expense increased from Dec. 2022 (kr0.06 Mil) to Dec. 2023 (kr0.07 Mil) and increased from Dec. 2023 (kr0.07 Mil) to Dec. 2024 (kr0.21 Mil).


SciBase Holding AB Other Operating Expense Historical Data

The historical data trend for SciBase Holding AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciBase Holding AB Other Operating Expense Chart

SciBase Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.15 0.06 0.07 0.21

SciBase Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 - 0.13 0.25 -0.16

SciBase Holding AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciBase Holding AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of SciBase Holding AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


SciBase Holding AB Business Description

Traded in Other Exchanges
N/A
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB Headlines

No Headlines